<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">Christopher M. Coleman et al. reported a unique nano-vaccine based on lipid nanoparticles carrying SARS-CoV and MERS-CoV spike proteins without any viral proteins which effectively-induced antibody responses in mice (Coleman et al. 
 <xref ref-type="bibr" rid="CR16">2014</xref>). Similarly, Hyo-Jung Park et al. developed two MERS-CoV vaccines from spike nanoparticles and spike protein-expressing recombinant adenovirus 5 (Park et al. 
 <xref ref-type="bibr" rid="CR48">2017</xref>). Both vaccines triggered immune responses of Th1 and Th2.
</p>
